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Background. Salmonella infections cause a disproportionately high number of deaths in Africa, especially among poor urban 
populations. The increasing level of multidrug-resistant (MDR) infections is a major cause of concern in these settings where alterna-
tive effective treatment is unavailable. Other options for management of these infections must be sought. The knowledge of hotspots 
in endemic settings can help to prioritize management and control measures in Kenya and the region. 
Methods. Using blood cultures, we investigated children presenting with fever of unknown origin for Salmonella infections. 
We performed antimicrobial susceptibility testing and whole genome sequencing to further characterize Salmonella isolates. Using 
Global Positioning System technologies, we mapped Salmonella isolates to households of patients in the study site and determined 
risk factors associated with high concentration of cases in particular sites. 
Results. A total of 281 Salmonella species (149 from blood and 132 from fecal samples) from febrile children <5 years of age were 
studied. These consisted of 85 Salmonella Typhimurium, 58 Salmonella Enteritidis, 32 other nontyphoidal Salmonella (NTS) sero-
types, and 126 Salmonella Typhi. The prevalence of MDR invasive NTS (iNTS) was 77.2%, with 15% resistant to ceftriaxone, a drug 
that is last-line treatment for iNTS and other severe gram-negative infections in Kenya. Invasive NTS and S. Typhi together mapped 
around common water vending points and close to sewer convergence points in the highly populated village.
Conclusions. These hotspots could be targeted for management and control strategies, including a combined introduction of 
typhoid and iNTS vaccines, aimed at reducing transmission in these endemic settings.
Keywords. nontyphoidal Salmonella; hotspots; multidrug resistant; Kenya.
Nontyphoidal Salmonella (NTS) disease, a major cause of 
diarrheal disease globally, is estimated to cause 93 million 
enteric infections and 155 000 diarrheal deaths each year [1]. 
The Institute for Health Metrics and Evaluation estimated that 
enteric NTS disease was associated with 4 847 000 disability-ad-
justed life-years (DALYs) lost (70 DALYs /100 000 population) 
and 81 300 diarrheal deaths (1.2 deaths/100 000 population) 
in 2010 [2]. However, in sub-Saharan Africa (SSA), incidence 
of invasive NTS (iNTS) disease is even more widespread and 
severe (227 [range, 152–341] cases/100 000 population) and 
comprises the largest number of cases (1.9 [range, 1.3–2.9] 
million cases) [3, 4]. Among iNTS cases, it is estimated that 
63.7% occurred in children <5 years of age globally, and 68.3% 
occurred in children <5 years of age in SSA [4]. The incidence of 
iNTS in a single site in Kenya in children aged <5 years was 36.6 
per 100 000 person-years, being highest in infants aged <7 days 
(174/100 000 person-years) [5]. Risk factors for iNTS disease 
were human immunodeficiency virus (HIV) infection, malaria, 
and malnutrition; the case fatality ratio was 22.1% (71/321) in 
children aged <5 years and 36.7% (11/30) in adults. In cases that 
are not promptly treated, mortality can be >30% [6].
In SSA, multidrug-resistant (MDR) Salmonella serotype 
Typhimurium of a novel sequence type (ST) 313 has been 
reported from several countries including Kenya [7], Malawi 
[8], the Democratic Republic of the Congo [9], Nigeria [10], 
Ghana [11], South Africa [12], and Mozambique [13] where 
iNTS is endemic and produces septicemia in the absence of gas-
troenteritis. So far no animal reservoir has been identified, and 
it is hypothesized that transmission is human to human [14].
Increasing antimicrobial resistance in iNTS is of great global 
concern, and the situation is even more acute in low-income 
countries where empiric oral options for effective treatment 
of life-threatening invasive disease are being rapidly eroded. 
MDR iNTS has been reported in Kenya and Malawi [8, 15] 
and in other parts of SSA [16–18], posing a major challenge to 
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treatment and management options. Where new effective anti-
microbials are lacking, developments in vaccines offer hope for 
reducing the burden of iNTS in endemic settings in SSA.
Nairobi, Kenya’s largest urban center, has an estimated pop-
ulation of 4.5 million, a third of whom live in informal set-
tlements that lack proper sanitary and clean water facilities. 
MDR enteric pathogens in these settings are a common cause 
of community-acquired infections [7, 19]. In the early 1990s, 
only 34.2% of iNTS from cases in urban sites were MDR (resist-
ant to ≥3 antibiotics); the most common resistance phenotype 
was ampicillin, tetracycline, and co-trimoxazole in two-thirds 
of the isolates and chloramphenicol or ampicillin, tetracycline, 
and gentamicin in 15% of the isolates [7]. There were no sig-
nificant differences in prevalence of resistance between the 2 
major serotypes, S. Typhimurium and Salmonella Enteritidis. 
Ciprofloxacin and ceftriaxone were the only antibiotics to which 
all NTS isolates were fully susceptible. In subsequent studies in 
2000–2010, the proportion of MDR isolates has risen to >75% 
[7]. Similarly, in Malawi [20], MDR S. Typhimurium accounts 
for 90% of all NTS bacteremia isolates from HIV-infected adults 
and from children <5 years of age with various causes of immu-
nosuppression. In West Africa, MDR was common among iNTS 
cases, with decreased ciprofloxacin susceptibility and extend-
ed-spectrum β-lactamase production being reported in Ghana 
[11] and Burkina Faso [21]. In this review, we report an effort 
to map hotspots of invasive Salmonella disease in an informal 
settlement 20 km east of Nairobi city that can inform plans for 
targeted prevention strategies.
METHODS
Brief Description of the Study Site
Our study site was Mukuru informal settlement, which is sit-
uated about 25 km east of Nairobi city center. It is one of the 
largest slums in the city with a population of around 250 000 
people. The informal settlements are made up of improvised 
temporary houses often made from scrap materials, such as 
corrugated metal sheets, plywood, and polythene sheets. The 
settlements are densely populated and characterized by limited 
basic services and infrastructure for providing clean water, san-
itation facilities, solid-waste management, roads, drainage, and 
electricity. In addition to poverty, a number of factors associated 
with informal settlements, including overcrowding, substandard 
housing, unclean and insufficient quantities of water, and inad-
equate sanitation, contribute to a high incidence of infectious 
diseases and increased mortality among those <5  years of age 
[22, 23]. Mukuru informal settlement is divided into 86 main 
villages: Mukuru Lunga-Lunga, Mukuru kwa Sinai, Mukuru kwa 
Reuben, Mukuru kwa Njenga, Mukuru Kayaba, and Mukuru 
North. The 2 major villages within the settlement, Mukuru 
kwa Njenga and Mukuru kwa Reuben with a combined popu-
lation of 120 000, were mapped and a census was done. Mukuru 
kwa  Reuben was demarcated into 9 zones with 7037 blocks, 
whereas Mukuru kwa Njenga had 8 zones with 8059 blocks 
(Figure  1). The area within the 2 villages studied consisted of 
mainly dwellings (98%) and a few godowns (ie, warehouses; 
2% of the buildings) used by small-scale industrial set-ups in 
the outskirts of the villages. In the villages, a few goats and pigs 
owned by enterprising individuals roam the streets, eating from 
garbage dumps from vendors who sell vegetables along the vil-
lage streets. In addition, the informal settlement in general has 
poor drainage, a common site of surface effluent throughout 
most of the mapped area. Three community health centers serve 
the population here: Missionaries of Mary, Mukuru Ruben, and 
Mukuru City Council. In total, 32 000 households were mapped.
Study Subjects and Specimen Collection
The study subjects were patients aged 0–16 years who visited 
any of the 3 outpatient clinics in the study area seeking medi-
cal attention. The cases for iNTS investigation were defined as 
patients who had a subjective history of at least 3 days of fever 
and an axillary temperature of at least 37.5°C or who presented 
with a history of fever of any duration and had an axillary tem-
perature of at least 37.5°C at presentation. Blood samples of 
1–3 mL from children <5 years of age, and 5–10 mL from those 
aged 5–16  years, were taken and aseptically transferred into 
Bactec blood culture media (BD, Franklin Lakes, New Jersey). 
In addition, a fecal swab sample was taken from each patient 
using a sterile cotton-tipped swab and transferred into Cary-
Blair transport media. The samples were then was transferred to 
the laboratory at the Centre for Microbiology Research, Kenya 
Medical Research Institute (KEMRI) within 4 hours. A struc-
tured questionnaire was used to elucidate the following infor-
mation from each patient: clinical manifestations (eg, vomiting, 
fever, and/or dehydration), demographic data (age, sex, and 
residence), and types of stool samples (watery, mucous, bloody, 
or other form).
Laboratory Procedures
Detection of Bacterial Pathogens
Blood cultures were incubated at 37°C in a computerized Bactec 
9050 Blood Culture System (BD), and subcultured after 24 
hours onto blood, chocolate, and MacConkey agar plates. The 
blood cultures were subsequently observed for a further 7 days 
for signs of bacterial growth (autodetection). A final subculture 
was performed for all blood cultures on the eighth day regard-
less of the state of bacterial growth. From the subcultures, bac-
terial isolates were identified using biochemical tests on API20E 
strips (API System, Montalieu Vercieu, France) and further 
typed by species-specific serological tests.
Fecal Cultures
The rectal swab or loopful of the stool specimen was trans-
ported to the KEMRI laboratory and initially cultured on 
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selenite F (Oxoid, Basingstoke, United Kingdom) broth aero-
bically at 37°C overnight. Broth cultures were then subcultured 
on MacConkey agar and Salmonella-Shigella agar (Oxoid) and 
incubated at 37°C overnight. To identify suspected Salmonella 
bacteria, nonlactose-fermenting colonies were biochemically 
tested using triple sugar iron slants. From the subcultures, 
bacterial isolates were identified using biochemical tests on 
API20E strips and further typed by species-specific serolog-
ical tests.
Antibiotic Susceptibility Testing
Antibiotic susceptibility testing was performed using the disk 
diffusion technique for all commonly used antimicrobials in 
Kenya on Mueller-Hinton agar (Oxoid, Basingstoke, United 
Kingdom). For gram-negative enteric bacterial species (this 
includes ampicillin 10  µg, tetracycline 30  µg, gentamicin 
10 µg, co-trimoxazole 25 µg, chloramphenicol 30 µg, co-amox-
iclav 20:10 µg, cefuroxime 30  µg, ceftazidime 30  µg, ceftriax-
one 30 µg, cefotaxime 30 µg, ciprofloxacin 5 µg, and nalidixic 
acid 10 µg), minimum inhibitory concentrations (MICs) were 
performed using E-test strips (AB BIODISK, Solna, Sweden). 
Results were interpreted according to the guidelines provided 
by the Clinical and Laboratory Standards Institute [24].
Genetic Typing of Sequence Types and NTS Isolates
Genomic DNA from the NTS isolates was extracted using the 
Wizard Genomic DNA Extraction Kit (Promega, Fitchburg, 
Wisconsin). Two micrograms of genomic DNA was subjected 
to indexed whole genome sequencing (WGS) on an Illumina 
Hiseq 2000 platform at the Wellcome Trust Sanger Institute, to 
generate 100-bp paired-end reads. WGS was performed using 
new sequencing technologies (Illumina, 454) and exploited 
genotyping platforms (GoldenGate) for high-resolution and 
high-throughput sample analysis. The likelihood test ratios 
were determined as previously described [25]. The support for 
nodes on the trees was checked using 100 random bootstrap 
replicates. Resulting phylogenetic trees were visualized using 
the FigTree package version 1.4.0 (http://tree.bio.ed.ac.uk/soft-
ware/figtree/). Subtrees were extracted for each subclade, which 
are therefore each rooted by the other subclades.
Figure 1. Demographic and disease surveillance site in the Mukuru informal settlement.The 2 villages where households were mapped (Mukuru kwa Ruben and Mukuru 
kwa Njenga) and a census was done are shown as darkened dots, and the numbers show the respective zones (zones 1–9 for Mukuru kwa Ruben and 1a to 8a for Mukuru 
kwa Njenga) for each village.
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Mapping Hotspots for NTS and Antimicrobial Resistance
Using the MicroReact software [26], the microbiological data on 
serotypes and genotyping data were entered into a model along 
with Global Positioning System (GPS) coordinates for each 
patient to map to potential spatial risk factors (eg, proximity to 
water or sewage sites, socioeconomic activities, health-seeking 
patterns).
Ethical Considerations
The study was approved by the Scientific and Ethics Review 
Unit of KEMRI (Scientific Steering Commitee number 2076). 
All parents and/or guardians of participating children were 
informed of the study objectives, and voluntary written consent 
was obtained before inclusion. A copy of the signed consent was 
filed and stored in password-protected cabinets at KEMRI.
RESULTS
Study Population and Microbiological Investigation
Between January 2013 and December 2017, a total of 4150 
blood cultures were processed from patients from the 3 outpa-
tient clinics situated in Mukuru informal settlement (Figure 1), 
with 72% of those suspected to have fever with or without 
diarrhea being <5  years of age. From these, a total 147 of 
Salmonella species consisting of 50 (33.6%) S. Typhimurium, 
34 (22.8%) S. Enteritidis, 48 (32.2%) Salmonella Typhi, and 17 
(11.4%) other serotypes were isolated and further character-
ized using WGS.
From a total of 4055 fecal samples of the same patients 
(95 of whom could not give a fecal sample), 35 (26.5%) S. 
Typhimurium, 24 (18.2%) S. Enteritidis, 58 (43.9%) S. Typhi, 
and 15 other serotypes were isolated (Table 1). Of these, a total 
of 8 S. Typhimurium, 5 S. Enteritidis, and 22 S. Typhi came 
from patients whose blood cultures were also positive.
Antimicrobial Susceptibility Testing
From a total of 101 iNTS isolates, 69 (68.3%) were resistant to 
at least one antimicrobial, and 58 (57.2%) were resistant to ≥2 
commonly available antimicrobials. The most common resist-
ance phenotypes were resistance to ampicillin, chlorampheni-
col, and co-trimoxazole. In addition, 15% of iNTS isolates were 
resistant to extended-spectrum β-lactams (cefotaxime or ceftri-
axone), whereas 6% were resistant to ciprofloxacin.
Mapping of Serotypes and Genotypes
Using GPS and proximity distance data, the iNTS and S. Typhi 
isolates appeared to be concentrated around the village, with 
the highest around water vending points, sewer convergence 
points, and shared toilet facilities (Figure 2). Indeed, the 2 infec-
tions iNTS and S. Typhi were closely related in geographic dis-
tribution in the mapped area of the study. From WGS, the main 
genotypes for S. Typhimurium were ST19 (33%) and ST313 
(67%), whereas all S. Enteritidis isolates were ST11. Of the S. 
Typhi isolates sequenced, 96% were ST1, whereas 2% and 1% 
were ST2 and ST2230, respectively.
DISCUSSION
Since 2000, the prevalence of multidrug resistance in invasive 
Salmonella disease especially for commonly available anti-
microbials has been increasing steadily in Kenya [7, 15]. The 
increasing rate of antimicrobial resistance for iNTS is worrying 
as more effective antimicrobials are either unavailable or too 
expensive to be afforded by public healthcare facilities. Recently 
we documented the emergence of ceftriaxone-resistant invasive 
S. Typhimurium ST313 isolates in Kenya [25]. The spectrum of 
resistance in these isolates extends beyond the cephalosporins 
to include tetracyclines, co-trimoxazole, chloramphenicol, and 
aminoglycosides such as streptomycin. However, these isolates 
have remained susceptible to carbapenems and fluoroquinolo-
nes, but rising MICs for the latter antimicrobials are being 
observed in recent iNTS isolates. Illegal, commonly available 
antimicrobials are sold over the counter in these settings and 
indeed in many urban areas, and this would further fuel the rise 
of resistance. In Southeast Asia, fluoroquinolone resistance is 
now a growing problem in iNTS, with the first report of cip-
rofloxacin resistance in Salmonella enterica infection (eventu-
ally leading to treatment failure) being published in 1990 [27]. 
Alternative means for management of life-threatening iNTS 
will be required to forestall the high mortality rates associated 
with invasive disease in our informal settlement where disease 
is endemic.
In our study, typhoid affected most of the older children (72% 
were >5 years of age), whereas iNTS affected mainly younger 
children (78% were <5 years of age) and symptoms were often 
more severe compared with those of typhoid fever. In studies in 
rural and urban informal settlements in Kenya, the local min-
imum incidence of community-acquired iNTS was estimated 
Table 1. Distribution of Salmonella Serotypes From Blood and Stool of 
Patents With Fever, Mukuru Informal Settlement, Kenya
Serotype MMM MR MCC
Total, 
No. (%)
Blood n = 1713 n = 1389 n = 1056
 Salmonella Typhimurium 23 18 9 50 (33.6)
 Salmonella Enteritidis 11 12 11 34 (22.8)
 Other NTS 2 5 10 17 (11.4)
 Salmonella Typhi 25 13 10 48 (32.2)
149
Stool n = 1827 n = 1205 n = 1123
 Salmonella Typhimurium 16 14 5 35 (26.5)
 Salmonella Enteritidis 10 9 5 24 (18.2)
 Other NTS 7 5 3 15 (11.4)
 Salmonella Typhi 20 21 17 58 (43.9)
132
Data are presented as No. unless otherwise indicated.
Abbreviations: MCC, Mukuru City Council; MMM, Missionaries of Mary; MR, Mukuru 
Ruben; NTS, nontyphoidal Salmonella.
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at 166 per 100 000 per year for children <5  years of age [5, 
28]. The adjusted incidence in the rural site was 568/100 000 
person-years, and that in the urban site was 51/100 000 per-
son-years. The incidence was highest in children <5 years old 
with mortality up to 28%. However, rates in both sites were 
thought to be underestimated by 4- to 8-fold due to incomplete 
blood culturing of febrile patients and use of healthcare facili-
ties other than those used for the study [28], whereas typhoid 
disease was more important among the children in poor infor-
mal urban settings in Kibera, very similar to our study site in 
Mukuru informal settlement. These 2 informal settlements 
together account for nearly 800 000 population. However, our 
study observed almost equally high prevalence of both iNTS 
and typhoid in the same settings of the poor informal settle-
ment. This would call for a common effort to control both of 
these endemic infections.
The STs most associated with iNTS disease are S. 
Typhimurium ST313 (67%) and S. Enteritidis ST11 (100%). 
Previous studies have shown that ST313 has been increasing in 
incidence across many SSA countries and now dominates most 
invasive Salmonella disease occurring in children <5  years of 
age [8, 29, 30]. In comparison, S. Enteritidis and S. Typhi man-
ifest as a milder disease, with typhoid occurring more in older 
(aged 5–16 years) children.
As more people migrate into cities looking for jobs, the 
informal settlements are likely to grow and, unfortunately, the 
infrastructure, including sanitation, sewer disposal, and pro-
vision of clean drinking water, does not keep pace with this 
population growth. It will be important to consider short- to 
medium-term measures to prevent and control endemic infec-
tions including iNTS in this vulnerable population. There are 
already well-studied and World Health Organization (WHO)–
recommended vaccines for typhoid [31]; these should be rolled 
out immediately in these settings. The mapping of hotspots in 
these endemic settings where 250 000 people live in densely 
populated structures would be an ideal starting point for such 
an iNTS prevention strategy. In addition, as observed in the 
hotspot map, iNTS and typhoid appear to be closely related in 
Figure 2. Hotspots of Salmonella serotypes in the 4 villages of Mukuru informal settlement. To the southeast of the map are godowns (warehouses) used by small-scale 
light industries.
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their dispersion in the 2 villages. It is likely that the 2 infections 
have similar routes of transmission. Previously we showed that 
iNTS disease in Kenya and the region is likely to be transmitted 
person to person [14], very similar to typhoid. Previous stud-
ies have also shown that local strains of S. Typhimurium ST313 
[32] and S. Enteritidis ST11 [33] have gradually shed genes in a 
similar manner to S. Typhi evolution toward becoming human-
adapted pathogens. Hence, methods for intervention to control 
one disease will easily lend to control and management of the 
other. As efforts toward developing vaccines against the most 
common and severe disease causing serotype iNTS serotype are 
under way, it would be prudent to consider deployment of vac-
cines initially in the mapped hotspots of these infections in the 
endemic sites. 
In conclusion, we have mapped hotspots of iNTS in an 
endemic setting for both typhoid and NTS disease. The increas-
ing prevalence of multidrug resistance among iNTS strains is 
another compelling reason to consider these hotspots for man-
agement through vaccination programs that could also include 
WHO-recommended typhoid vaccines.
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